ANI Pharmaceuticals (ANIP)
(Real Time Quote from BATS)
$61.09 USD
-1.10 (-1.77%)
Updated Jul 22, 2024 11:14 AM ET
2-Buy of 5 2
B Value A Growth D Momentum A VGM
Earnings News For ANIP
-
ANI: Q1 Earnings Snapshot
-
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
-
ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?
-
ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
-
ANI: Q4 Earnings Snapshot
-
ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 Guidance
-
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
ANI: Q3 Earnings Snapshot
-
ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
-
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
ANI Pharmaceuticals (ANIP) Beats Q2 Earnings and Revenue Estimates
-
ANI: Q2 Earnings Snapshot
-
ANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
-
ANI Pharmaceuticals (ANIP) to Post Q2 Earnings: What's in Store?
-
ANI Pharmaceuticals (ANIP) Beats Q1 Earnings and Revenue Estimates
-
ANI: Q1 Earnings Snapshot
-
ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
-
ANI: Q4 Earnings Snapshot
-
ANI Pharmaceuticals (ANIP) Q4 Earnings and Revenues Top Estimates
-
ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance
-
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: Should You Buy?
-
ANI Pharmaceuticals (ANIP) Surpasses Q3 Earnings and Revenue Estimates
-
ANI: Q3 Earnings Snapshot
-
ANI Pharmaceuticals Reports Third Quarter 2022 Financial Results; Reports Record Net Revenues
-
ANI Pharmaceuticals (ANIP) Tops Q2 Earnings and Revenue Estimates